Stereotaxic lesions and movement disorders in monkeys.
D000818:Animals; D001921:Brain / Q000187:drug effects; D001931:Brain Mapping; D002090:Butyrophenones / Q000494:pharmacology; D002375:Catalepsy; D002389:Catatonia; D002531:Cerebellum / Q000503:physiopathology; D002819:Chorea / Q000139:chemically induced; D000882:Haplorhini; D006801:Humans; D007034:Hypothalamus, Posterior / Q000503:physiopathology; D007980:Levodopa / Q000494:pharmacology; D008636:Mesencephalon / Q000503:physiopathology; D008781:Methyltyrosines / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009044:Motor Cortex / Q000503:physiopathology; D009069:Movement Disorders / Q000209:etiology; D010276:Parasympatholytics / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology; D011149:Pons / Q000503:physiopathology; D012110:Reserpine / Q000494:pharmacology; D013238:Stereotaxic Techniques; D013378:Substantia Nigra / Q000503:physiopathology; D014202:Tremor / Q000209:etiology
D002090:Butyrophenones; D008781:Methyltyrosines; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D010640:Phenothiazines; D007980:Levodopa; D012110:Reserpine